Skip to main content

Advertisement

Log in

Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract.

We report the successful administration of interleukin-11 (IL-11 or oprelvekin), a promoter of megakaryocyte maturation, to a 54-year-old male Jehovah's Witness with hepatic cirrhosis and hypersplenic thrombocytopenia requiring surgery for symptomatic interstitial cystitis. This observation suggests that oprelvekin might be crucial in the acute management of certain types of hypersplenic thrombocytopenias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ustun, .C., Dainer, .P. & Faguet, .G. Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient. Ann Hematol 81, 609–610 (2002). https://doi.org/10.1007/s00277-002-0507-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-002-0507-y

Navigation